https://www.selleckchem.com/pr....oducts/dl-buthionine
A face-to-face consensus meeting with key stakeholders will be conducted to finish a final COS and recommend measurement instruments for each outcome. RESULTS We will develop a COS that should be reported in future clinical trials to evaluate the effectiveness of PI treatment. DISCUSSION The COS will follow current guidance to develop a high-quality COS in the field of PI treatment to reduce heterogeneity in trial reporting, facilitate valid comparisons of new therapies, and improve the quality of clinical trials.BACKG
Like
Comment
Share
